Action HTGMQ HTG MOLECULAR DIAGNOSTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues HTG Molecular Diagnostics, Inc.

Actions

HTGMQ

US40434H3021

Marché Fermé - OTC Markets
Autres places de cotation
 15:31:07 26/06/2024 		Varia. 5j. Varia. 1 janv.
0,0015 USD 0,00% Graphique intraday de HTG Molecular Diagnostics, Inc. -40,00% +15,38%
2023 Nomination d'un administrateur/examinateur dans le cadre du chapitre 11 pour HTG Molecular Diagnostics, Inc. CI
2023 Htg Molecular Diagnostics, Inc. annonce la fin de l'emploi de Byron T. Lawson en tant que vice-président principal et directeur commercial CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization
Top Premarket Gainers
HTG Highlights the Advantages of Its Drug Discovery Engine
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)
HTG Provides Update on Drug Discovery Partnering Initiative
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HTGMQ
  4. Actualités HTG Molecular Diagnostics, Inc.
  5. Autres langues